Precision medicine for metastatic breast cancer—limitations and solutions

被引:0
|
作者
Monica Arnedos
Cecile Vicier
Sherene Loi
Celine Lefebvre
Stefan Michiels
Herve Bonnefoi
Fabrice Andre
机构
[1] Gustave Roussy and Université Paris Sud,Department of Medical Oncology
[2] INSERM Unit U981,Department of Biostatistics and Epidemiology
[3] Gustave Roussy and Université Paris Sud,Division of Research and Cancer Medicine
[4] Gustave Roussy and Université Paris Sud,Department of Medical Oncology and INSERM U916
[5] Peter MacCallum Cancer Centre,undefined
[6] University of Melbourne,undefined
[7] Institut Bergonié,undefined
来源
关键词
D O I
暂无
中图分类号
学科分类号
摘要
Recent research data defining the genomic landscape of breast cancer have reinforced the notion that this disease is driven by genomic alterationsSo far very few gene drivers validated in breast cancer have been identified, including ESR1, ERBB 2, PIK3CA and ATK1Identification of drivers, characterization of resistant clones, identification of DNA repair defects and mechanisms of immune suppression are potential uses of genomics to personalize medicineThe development of precision medicine for the treatment of breast cancer has several major challenges that include low frequency of targetable molecular alterations, feasibility of high-throughput technologies and availability of targeted therapy
引用
收藏
页码:693 / 704
页数:11
相关论文
共 50 条
  • [31] Is Precision Medicine Ready for Use in Breast Cancer?
    Rugo, Hope S.
    Clinical Advances in Hematology & Oncology, 2016, 14 (12) : 964 - 966
  • [32] COGNITION - Precision Medicine for early Breast Cancer
    Pixberg, C.
    Von Au, A.
    Thewes, V
    Schulze, M.
    Hlevnjak, M.
    Fremd, C.
    Michel, L.
    Elgaafary, S.
    Hug, S.
    Pfuetze, K.
    Wolf, S.
    Hutter, B.
    Ishaque, N.
    Hirsch, S.
    Gieldon, L.
    Stenzinger, A.
    Flechtenmacher, C.
    Smetanay, K.
    Romy, K.
    Sprick, M.
    Trumpp, A.
    Sinn, H. P.
    Jaeger, D.
    Zapatka, M.
    Mavratzas, A.
    Stieber, A.
    Gomez, C.
    Harcos, A.
    Golatta, M.
    Heil, J.
    Schlenk, R.
    Schuetz, F.
    Lichter, P.
    Schneeweiss, A.
    GEBURTSHILFE UND FRAUENHEILKUNDE, 2020, 80 (06) : E54 - E54
  • [33] Toward precision medicine in inflammatory breast cancer
    Viale, Giulia
    Marra, Antonio
    Curigliano, Giuseppe
    Criscitiello, Carmen
    TRANSLATIONAL CANCER RESEARCH, 2019, 8 : S469 - S478
  • [34] Breast Cancer Prevention in the Era of Precision Medicine
    Narod, Steven A.
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2015, 107 (05):
  • [35] Possibilities and limitations of surgery in the treatment of metastatic breast cancer
    Zimmermann, T
    Winking, M
    Kelm, C
    Reinhold, L
    Padberg, W
    MEDIZINISCHE WELT, 1998, 49 (09): : 418 - 423
  • [36] A cancer precision medicine platform for multiple simultaneous genomic assays from metastatic biopsies (bx) in ER plus metastatic breast cancer.
    Wagle, Nikhil
    Helvie, Karla
    Lloyd, Maxwell R.
    Marini, Lori
    Waks, Adrienne Gropper
    Cohen, Ofir
    Oh, Coyin
    Sougnez, Carrie
    Oliver, Nelly
    Quartey, Qaren
    Rotem, Asaf
    Shah, Parin
    Lindeman, Neal Ian
    Krop, Ian E.
    Garraway, Levi A.
    Winer, Eric P.
    Lin, Nancy U.
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [37] Clinical management of metastatic colorectal cancer in the era of precision medicine
    Ciardiello, Fortunato
    Ciardiello, Davide
    Martini, Giulia
    Napolitano, Stefania
    Tabernero, Josep
    Cervantes, Andres
    CA-A CANCER JOURNAL FOR CLINICIANS, 2022, 72 (04) : 372 - 401
  • [38] Precision oncology in metastatic colorectal cancer — from biology to medicine
    Federica Di Nicolantonio
    Pietro Paolo Vitiello
    Silvia Marsoni
    Salvatore Siena
    Josep Tabernero
    Livio Trusolino
    Rene Bernards
    Alberto Bardelli
    Nature Reviews Clinical Oncology, 2021, 18 : 506 - 525
  • [39] Systemic treatment for metastatic colorectal cancer in the era of precision medicine
    Sandhu, Jaideep
    Lavingia, Viraj
    Fakih, Marwan
    JOURNAL OF SURGICAL ONCOLOGY, 2019, 119 (05) : 564 - 582
  • [40] Precision oncology in metastatic colorectal cancer - from biology to medicine
    Di Nicolantonio, Federica
    Vitiello, Pietro Paolo
    Marsoni, Silvia
    Siena, Salvatore
    Tabernero, Josep
    Trusolino, Livio
    Bernards, Rene
    Bardelli, Alberto
    NATURE REVIEWS CLINICAL ONCOLOGY, 2021, 18 (08) : 506 - 525